Ignite Creation Date:
2024-05-06 @ 3:54 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04797143
Status:
RECRUITING
Last Update Posted:
2023-04-12
First Post:
2021-03-11
Brief Title:
Impact of a Multidisciplinary Consultation Program on Drug Adherence in First Oral Anticancer Treatment
Sponsor:
Centre Hospitalier Universitaire Amiens
Organization:
Centre Hospitalier Universitaire Amiens
Study Overview
Official Title:
Impact of a Multidisciplinary Consultation Program on Drug Adherence in First Oral Anticancer Treatment
Status:
RECRUITING
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IMPAM
Brief Summary:
Oncology management has changed dramatically over the last decade with the approval and rapid adoption of newly targeted oral oncology medications The movement to oral oncology medications has altered the balance of risks and adverse effects AEs in the treatment of cancer care These treatments are associated with a different constellation of AEs and drug interactions Patients receiving treatment with oral anticancer treatment OAT encounter several barriers to adherence which may include limited access to specialty medications severe adverse effects complex medication regimens and special handling precautions Medication nonadherence not only reduces the efficacy of drug therapy but also has the potential to increase healthcare expenditures due to disease-related hospitalizations The purpose of this study is to evaluate the drug adherence in cancer patients using the medication possession ratio MPR before and after the implementation of a multidisciplinary consultation program MCP on initiation of OAT
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None